CME GROUP INC.

Listed Company

CMECIK 0001156375NasdaqLarge AcceleratedSecurity & Commodity Brokers, Dealers, Exchanges & ServicesDelawareFY ends Dec 31

Period

FY 2025

Revenue

$6.52B

Net Income

$4.07B

Total Assets

$198.42B

Equity

$28.73B

Shares Out

66.64M

Op. Cash Flow

$4.28B

CME$245.03−11.80% · past yearDBEQ Basic

Daily closing prices

Business

CME Group operates global derivatives exchanges and clearing houses enabling clients to trade futures, options, cash and OTC products across interest rates, equities, foreign exchange, and commodities. The company provides electronic trading platforms (CME Globex, BrokerTec, EBS), central counterparty clearing services, market data products and analytics. CME Group serves professional traders, financial institutions, corporations, governments and central banks through its exchange and clearing divisions, plus cash markets and data services businesses.

Summary from 10-K filed 2026-02-26

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Total Revenues	6,521	6,130	5,579	5,019	4,690
Compensation and benefits	907	850	829	753	837
Technology	283	256	219	189	193
Professional fees and outside services	151	133	144	137	152
Amortization of purchased intangibles	223	222	227	228	238
Depreciation and amortization	108	115	126	135	148
Licensing and other fee agreements	371	355	323	320	237
Other	249	268	276	242	241
Total Expenses	2,291	2,199	2,143	2,004	2,045
Operating Income	4,230	3,932	3,436	3,016	2,645
Investment income	5,737	4,079	5,275	2,198	307
Interest and other borrowing costs	−173	−161	−159	−163	−167
Equity in net earnings (losses) of unconsolidated subsidiaries	372	351	297	301	246
Other income (expense)	−4,834	−3,659	−4,695	−1,862	343
Total Non-Operating	1,101	610	718	474	728
Income before Income Taxes	5,331	4,541	4,154	3,490	3,374
Income tax provision	1,258	1,016	927	799	737
Net income	4,072	3,526	3,226	2,691	2,637
Net income attributable to CME Group	4,072	3,526	3,226	2,691	2,637
Net Income Attributable to Common Shareholders of CME Group	4,021	3,482	3,186	2,657	2,617
Basic (per share)	11.18	9.69	8.87	7.41	7.3
Diluted (per share)	11.16	9.67	8.86	7.4	7.29
Basic (shares)	360	359	359	359	358
Diluted (shares)	360	360	360	359	359

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash and cash equivalents	4,417	2,892	2,912	2,720	2,835
Marketable securities	125	113	112	96	115
Accounts receivable, net of allowance	639	573	536	483	435
Other current assets	522	559	1,138	530	428
Performance bonds and guaranty fund contributions	159,656	98,895	90,193	135,249	157,950
Total current assets	165,359	103,034	94,890	139,078	161,762
Property, net of accumulated depreciation and amortization	363	386	410	456	505
Intangible assets-trading products	17,175	17,175	17,175	17,175	17,175
Intangible assetsother, net	2,611	2,822	3,050	3,270	3,532
Goodwill	10,515	10,487	10,495	10,483	10,528
Other assets	2,402	3,544	3,686	3,714	3,278
Total Assets	198,424	137,447	129,706	174,176	196,780
Accounts payable	72	80	91	121	49
Short-term debt	0	750	0	16	749
Other current liabilities	569	2,589	3,134	2,301	1,651
Performance bonds and guaranty fund contributions	159,656	98,895	90,193	135,249	157,950
Total current liabilities	160,297	102,314	93,417	137,688	160,398
Long-term debt	3,422	2,678	3,425	3,422	2,696
Deferred Income Tax Liabilities, Net	5,242	5,247	5,328	5,361	5,390
Other liabilities	735	721	798	826	897
Total Liabilities	169,696	110,960	102,968	147,297	169,381
Preferred stock, $0.01 par value, 10,000 shares authorized, none issued or outstanding	0	0	0	0	0
Additional paid-in capital	22,210	22,403	22,335	22,262	22,190
Retained earnings	6,433	4,186	4,455	4,747	5,152
Accumulated other comprehensive income (loss)	82	−106	−56	−133	54
Total CME Group Shareholders' Equity	28,728	26,487	26,738	26,879	27,399
Total Liabilities and Shareholders' Equity	198,424	137,447	129,706	174,176	196,780

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Stock-based compensation	95	90	83	84	75
Net realized and unrealized gains on investments	−353	−4	−72	−5	−117
Deferred income taxes	−6	−66	−75	−23	35
Accounts receivable	−67	−39	−52	−51	−46
Other current assets	−18	665	−638	−77	−55
Other assets	50	75	92	87	61
Accounts payable	−8	−11	−31	73	−19
Income tax payable	91	−117	−77	−148	−121
Other current liabilities	87	−706	643	88	62
Other liabilities	−35	−55	−33	−67	−45
Other	38	−3	34	41	−20
Net Cash Provided by Operating Activities	4,277	3,691	3,454	3,056	2,402
Proceeds from maturities and sales of available-for-sale marketable securities	8	6	6	6	9
Purchases of available-for-sale marketable securities	6	5	4	4	8
Purchases of property, net	−84	−94	−76	−90	−127
Investments in business ventures	11	4	2	3	5
Proceeds from sale of business ventures	1,591	14	98	11	101
Net Cash Used in Investing Activities	1,499	−83	21	−490	58
Proceeds from debt, net of issuance costs	741	0	0	741	0
Repayment of other borrowings, including call premiums	−750	0	−16	−756	0
Cash dividends	−3,933	−3,584	−3,236	−2,634	−2,189
Payments for (Proceeds from) Derivative Instrument, Financing Activities	−266	0	0	—	0
Change in performance bond and guaranty fund contributions	60,761	8,703	−45,057	−22,700	71,168
Employee taxes paid on restricted stock vesting	−34	−33	−21	−25	−32
Other	−9	−9	−9	−8	−3
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation	56,510	5,077	−48,339	−25,382	69,909
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	62,285	8,684	−44,865	−22,816	72,370
Income taxes paid	1,164	1,197	1,072	973	755
Interest paid	136	130	130	133	133
Dividends declared	0	2,112	1,910	1,636	1,184

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Frequently asked questions

What is CME GROUP INC.'s CIK number?

CME GROUP INC.'s SEC CIK number is 0001156375 (1156375). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find CME GROUP INC.'s SEC filings?

All of CME GROUP INC.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

When did CME GROUP INC. last report earnings?

CME GROUP INC. (CME) most recently filed an earnings 8-K with the SEC on Apr 22, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001156375-26-000016). This is CME GROUP INC.'s most recent earnings filing of record — not a forecast of its next earnings date.

What is CME GROUP INC.'s most recent earnings 8-K?

CME GROUP INC.'s latest earnings 8-K (Item 2.02) was filed Apr 22, 2026 under accession 0001156375-26-000016. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.

View CME GROUP INC.'s latest earnings 8-K →
Look up any company's CIK number →